Invictus set to begin seismic programs

|

Published 21-APR-2021 12:26 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Invictus Energy (ASX:IVZ) has awarded its Seismic Acquisition contract to Polaris Natural Resources.

Polaris will conduct a 2D survey in the Cabora Bassa Basin, where IVZ operates its 80% owned Cabora Bassa Project in Zimbabwe.

The Cabora Bassa Project encompasses the Mzarabani Prospect, a multi-TCF and liquids rich conventional gascondensate target, which is potentially the largest, undrilled seismically defined structure onshore Africa. The prospect is defined by a robust dataset acquired by Mobil in the early 1990s that includes seismic, gravity, aeromagnetic and geochemical data.

The pending seismic program aims to refine the Mzarabani-1 drilling location and identify additional prospectivity for upcoming drilling campaigns.

“Our exploration program is on track, and the significant amount of preparatory work that we have undertaken is paying off, Invictus Managing Director Scott Macmillan commented.

“We are using a very experienced contractor and have put in place a very experienced team to run the program. The seismic program will enable us to refine the Mzarabani-1 target defined from the existing seismic dataset and help us fill our prospect inventory ahead of our basin opening drilling campaign. We are very excited to get our exploration program underway.”

It is able to do so after the Petroleum Exploration Development and Production Agreement (PEDPA) between Invictus’s 80% owned subsidiary, Geo Associates and the Republic of Zimbabwe was executed, with the agreement being signed on behalf of the Government of the Republic of Zimbabwe by the Minister for Mines and Mining Development, Hon. Winston Chitando in late March.

The PEPDA provides the framework for progression of the Cabora Bassa Project as well as the licence holder with the right to enter into a 25-year production licence following the exploration periods.

IVZ is currently in the second exploration period.

Read: Invictus shares surge as government paves the way for Cabora Project

Polaris is Canada’s longest standing seismic company and has conducted over 1,000 seismic projects since 1996.

The company was behind the first ‘low impact seismic crew’ into Africa in 2008.

Polaris has conducted over 15 projects in East Africa and has been well accepted in all communities where they have operated.

The proposed seismic survey will be conducted with a minimal environmental footprint and utilise existing roads and tracks wherever possible.

“Polaris is very pleased to support Invictus on this world class project,” Bill Mooney, Polaris CEO said.

“The combination of technologies being employed represent not only the lightest seismic footprint possible, but also allows for very fast and high resolution data acquisition.”

Barry Meikle has joined the Invictus team as Seismic Project Manager.

Meikle has extensive experience in onshore seismic acquisition projects in PNG with Total and Interoil and project management expertise with oil field service companies in East Africa.

Polaris will begin mobilising the seismic equipment and personnel to Harare in the coming weeks.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X